chr6-109743725-A-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014845.6(FIG4):​c.1090A>T​(p.Met364Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0499 in 1,612,658 control chromosomes in the GnomAD database, including 3,876 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.052 ( 405 hom., cov: 32)
Exomes 𝑓: 0.050 ( 3471 hom. )

Consequence

FIG4
NM_014845.6 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 8.93
Variant links:
Genes affected
FIG4 (HGNC:16873): (FIG4 phosphoinositide 5-phosphatase) The protein encoded by this gene belongs to the SAC domain-containing protein gene family. The SAC domain, approximately 400 amino acids in length and consisting of seven conserved motifs, has been shown to possess phosphoinositide phosphatase activity. The yeast homolog, Sac1p, is involved in the regulation of various phosphoinositides, and affects diverse cellular functions such as actin cytoskeleton organization, Golgi function, and maintenance of vacuole morphology. Membrane-bound phosphoinositides function as signaling molecules and play a key role in vesicle trafficking in eukaryotic cells. Mutations in this gene have been associated with Charcot-Marie-Tooth disease, type 4J. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016498268).
BP6
Variant 6-109743725-A-T is Benign according to our data. Variant chr6-109743725-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 137375.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-109743725-A-T is described in Lovd as [Benign]. Variant chr6-109743725-A-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.218 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FIG4NM_014845.6 linkc.1090A>T p.Met364Leu missense_variant Exon 10 of 23 ENST00000230124.8 NP_055660.1 Q92562
FIG4XM_011536281.4 linkc.1027A>T p.Met343Leu missense_variant Exon 10 of 23 XP_011534583.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FIG4ENST00000230124.8 linkc.1090A>T p.Met364Leu missense_variant Exon 10 of 23 1 NM_014845.6 ENSP00000230124.4 Q92562

Frequencies

GnomAD3 genomes
AF:
0.0524
AC:
7969
AN:
151972
Hom.:
404
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0234
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.116
Gnomad ASJ
AF:
0.0458
Gnomad EAS
AF:
0.229
Gnomad SAS
AF:
0.139
Gnomad FIN
AF:
0.0750
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.0335
Gnomad OTH
AF:
0.0597
GnomAD3 exomes
AF:
0.0791
AC:
19840
AN:
250962
Hom.:
1397
AF XY:
0.0772
AC XY:
10473
AN XY:
135638
show subpopulations
Gnomad AFR exome
AF:
0.0224
Gnomad AMR exome
AF:
0.155
Gnomad ASJ exome
AF:
0.0480
Gnomad EAS exome
AF:
0.207
Gnomad SAS exome
AF:
0.128
Gnomad FIN exome
AF:
0.0702
Gnomad NFE exome
AF:
0.0355
Gnomad OTH exome
AF:
0.0611
GnomAD4 exome
AF:
0.0497
AC:
72523
AN:
1460568
Hom.:
3471
Cov.:
31
AF XY:
0.0513
AC XY:
37301
AN XY:
726640
show subpopulations
Gnomad4 AFR exome
AF:
0.0217
Gnomad4 AMR exome
AF:
0.150
Gnomad4 ASJ exome
AF:
0.0474
Gnomad4 EAS exome
AF:
0.237
Gnomad4 SAS exome
AF:
0.125
Gnomad4 FIN exome
AF:
0.0671
Gnomad4 NFE exome
AF:
0.0325
Gnomad4 OTH exome
AF:
0.0591
GnomAD4 genome
AF:
0.0525
AC:
7980
AN:
152090
Hom.:
405
Cov.:
32
AF XY:
0.0589
AC XY:
4381
AN XY:
74342
show subpopulations
Gnomad4 AFR
AF:
0.0233
Gnomad4 AMR
AF:
0.117
Gnomad4 ASJ
AF:
0.0458
Gnomad4 EAS
AF:
0.229
Gnomad4 SAS
AF:
0.139
Gnomad4 FIN
AF:
0.0750
Gnomad4 NFE
AF:
0.0335
Gnomad4 OTH
AF:
0.0600
Alfa
AF:
0.0462
Hom.:
286
Bravo
AF:
0.0538
TwinsUK
AF:
0.0321
AC:
119
ALSPAC
AF:
0.0330
AC:
127
ESP6500AA
AF:
0.0216
AC:
95
ESP6500EA
AF:
0.0357
AC:
307
ExAC
AF:
0.0743
AC:
9017
Asia WGS
AF:
0.186
AC:
645
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Apr 22, 2021
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 05, 2014
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Amyotrophic lateral sclerosis type 11 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Charcot-Marie-Tooth disease type 4J Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Charcot-Marie-Tooth disease type 4 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
19
DANN
Benign
0.93
DEOGEN2
Benign
0.23
T
Eigen
Benign
-0.41
Eigen_PC
Benign
-0.11
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.93
D
MetaRNN
Benign
0.0016
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.7
N
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
1.1
N
REVEL
Benign
0.18
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.029
B
Vest4
0.26
MutPred
0.24
Loss of MoRF binding (P = 0.3574);
MPC
0.29
ClinPred
0.062
T
GERP RS
4.9
Varity_R
0.20
gMVP
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2295837; hg19: chr6-110064928; COSMIC: COSV57790546; COSMIC: COSV57790546; API